Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06551233
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-04-23
Brief Title:
Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer NMIBC
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Clinical Study on the Safety and Efficacy of 9MW2821 in Patients With High-risk Non-muscle-invasive Bladder Cancer NMIBC That Have Previously Failed to Intravesical Therapy
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assess the safety and efficacy of 9MW2821 in patients with high-risk non-muscle-invasive bladder cancer NMIBC who have previously failed to intravesical therapy Provide a new treatment option for patients with NMIBC recurrence reduce the risk of tumor recurrence decrease the rate of radical bladder surgery and enhance the quality of life for patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None